Literature DB >> 33665074

Studying Sjögren's syndrome in mice: What is the best available model?

Ghada Abughanam1, Ola M Maria2, Simon D Tran1.   

Abstract

Sjögren's syndrome (SS) is a common autoimmune disease characterized by lymphocytic infiltration and destruction of exocrine glands. The disease manifests primarily in the salivary and lacrimal glands, but other organs are also involved, leading to dry mouth, dry eyes, and other extra-glandular manifestations. Studying the disease in humans is entailed with many limitations and restrictions; therefore, the need for a proper mouse model is mandatory. SS mouse models are categorized, depending on the disease emergence into spontaneous or experimentally manipulated models. The usefulness of each mouse model varies depending on the SS features exhibited by that model; each SS model has advanced our understanding of the disease pathogenesis. In this review article, we list all the available murine models which have been used to study SS and we comment on the characteristics exhibited by each mouse model to assist scientists to select the appropriate model for their specific studies. We also recommend a murine strain that is the most relevant to the ideal SS model, based on our experience acquired during previous and current investigations.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Lacrimal glands; Salivary glands; Sjögren’s syndrome

Year:  2020        PMID: 33665074      PMCID: PMC7903136          DOI: 10.1016/j.jobcr.2020.12.001

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  123 in total

1.  Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3.

Authors:  R R Rivera; C P Johns; J Quan; R S Johnson; C Murre
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Sjogren's syndrome: a population based study of prevalence in Greece. The ESORDIG study.

Authors:  P I Trontzas; A A Andrianakos
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

3.  IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome.

Authors:  J B Brayer; S Cha; H Nagashima; U Yasunari; A Lindberg; S Diggs; J Martinez; J Goa; M G Humphreys-Beher; A B Peck
Journal:  Scand J Immunol       Date:  2001 Jul-Aug       Impact factor: 3.487

Review 4.  Sjögren's syndrome: an old tale with a new twist.

Authors:  Byung Ha Lee; Mauro A Tudares; Cuong Q Nguyen
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

5.  Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides.

Authors:  N L McCartney-Francis; D E Mizel; R S Redman; M Frazier-Jessen; R B Panek; A B Kulkarni; J M Ward; J B McCarthy; S M Wahl
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

Review 6.  NOD mice and autoimmunity.

Authors:  Christopher A Aoki; Andrea T Borchers; William M Ridgway; Carl L Keen; Aftab A Ansari; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2005-03-29       Impact factor: 9.754

7.  A novel NOD-derived murine model of primary Sjögren's syndrome.

Authors:  C P Robinson; S Yamachika; D I Bounous; J Brayer; R Jonsson; R Holmdahl; A B Peck; M G Humphreys-Beher
Journal:  Arthritis Rheum       Date:  1998-01

Review 8.  Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.

Authors:  M S Soyfoo; S Steinfeld; C Delporte
Journal:  Oral Dis       Date:  2007-07       Impact factor: 3.511

9.  Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

Authors:  Cintia S De Paiva; Cindy S Hwang; John D Pitcher; Solherny B Pangelinan; Ehsan Rahimy; Wei Chen; Kyung-Chul Yoon; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Rheumatology (Oxford)       Date:  2009-12-09       Impact factor: 7.580

10.  A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome.

Authors:  Y Inagaki; Y Jinno-Yoshida; Y Hamasaki; H Ueki
Journal:  J Dermatol Sci       Date:  1991-05       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.